What AMICUS THERAPEUTICS, INC.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 13 |
| Total trades | 0 | 48 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 352,414 |
| Disposed | 0 | 3,996,522 |
| Net activity | +0 | −3,644,108 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Roberts Eiry | Director | Apr 27 | Disposition to Issuer · D | −76,275 | $14.50 | −$1.11M | 0 |
| Campbell Bradley L | President and CEO | Apr 27 | Disposition to Issuer · D | −1,008,680 | $14.50 | −$14.6M | 0 |
| Harford Simon N.r. | Chief Financial Officer | Apr 27 | Disposition to Issuer · D | −143,595 | $14.50 | −$2.08M | 0 |
| Rosenberg Ellen | Chief Legal Officer | Apr 27 | Disposition to Issuer · D | −15,000 | $14.50 | −$218K | 0 |
| Rosenberg Ellen | Chief Legal Officer | Apr 27 | Disposition to Issuer · D | −463,898 | $14.50 | −$6.73M | 0 |
| Prout Samantha Whiteman | Chief Accounting Officer | Apr 27 | Disposition to Issuer · D | −125,951 | $14.50 | −$1.83M | 0 |
| Castelli Jeff | Chief Development Officer | Apr 27 | Disposition to Issuer · D | −427,089 | $14.50 | −$6.19M | 0 |
| Clark David Michael | Chief People Officer | Apr 27 | Disposition to Issuer · D | −221,811 | $14.50 | −$3.22M | 0 |
| Raab Michael | Director | Apr 27 | Disposition to Issuer · D | −115,857 | $14.50 | −$1.68M | 0 |
| Kelly Michael Aaron | Director | Apr 27 | Disposition to Issuer · D | −72,468 | $14.50 | −$1.05M | 0 |
| Bleil Lynn Dorsey | Director | Apr 27 | Disposition to Issuer · D | −113,941 | $14.50 | −$1.65M | 0 |
| Sblendorio Glenn | Director | Apr 27 | Disposition to Issuer · D | −142,564 | $14.50 | −$2.07M | 0 |
| Mcglynn Margaret G | Director | Apr 27 | Disposition to Issuer · D | −94,631 | $14.50 | −$1.37M | 0 |
| Whitman Burke W | Director | Apr 27 | Disposition to Issuer · D | −118,598 | $14.50 | −$1.72M | 0 |
| Wheeler Craig A | Director | Apr 27 | Disposition to Issuer · D | −84,631 | $14.50 | −$1.23M | 0 |
| Campbell Bradley L | President and CEO | Mar 02 | Open-market sale · S | −22,500 | $14.35 | −$323K | 998,680 |
| Campbell Bradley L | President and CEO | Jan 20 | Open-market sale · S | −75,000 | $14.31 | −$1.07M | 1,021,180 |
| Campbell Bradley L | President and CEO | Jan 20 | Exercise / conversion · M | +75,000 | $6.10 | +$458K | 1,096,180 |
| Prout Samantha Whiteman | Chief Accounting Officer | Jan 03 | Withheld — tax / exercise cost · F | −12,240 | $14.27 | −$175K | 125,951 |
| Rosenberg Ellen | Chief Legal Officer | Jan 03 | Withheld — tax / exercise cost · F | −29,683 | $14.27 | −$424K | 464,601 |
Loading...